1
|
Jia Q, Zhang X, Zhang A, Wu R, Liu Z, Chen Y, Wang J, Lv L. rLj-RGD4, the shortened peptide of rLj-RGD3 from Lampetra japonica, protects against cerebral ischemia/reperfusion injury via the PI3K/Akt pathway. Peptides 2020; 129:170310. [PMID: 32389578 DOI: 10.1016/j.peptides.2020.170310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Revised: 03/31/2020] [Accepted: 04/02/2020] [Indexed: 11/23/2022]
Abstract
The toxic RGD peptide, rLj-RGD4, characterized by 4 (Arg-Gly-Asp) (RGD) motifs, is a novel mutant of rLj-RGD3 from the salivary gland of Lampetra japonica. Our previous study showd that rLj-RGD3 exerts a protective effect against cerebral ischemia injury in rats. Through the induction of middle cerebral artery occlusion/reperfusion (MCAO) injuries in rats, the present study investigated the effects and the mechanism through which rLj-RGD4 protects against ischemic stroke. In rats, treatment with rLj-RGD4 2 h after MCAO enhanced survival rate, improved movement and ameliorated the severity of brain infarction and apoptosis by diminishing pathological changes. This study demonstrated that rLj-RGD4 can reverse the downregulation of Bcl2, and the upregulation of Caspase-3. Mechanistic studies showed that rLj-RGD4 upregulated the expression levels of FAK, p-FAK, PI3K and p-Akt. In contrast, caspase-3 expression was inhibited. These results showed that rLj-RGD4 may reduce cerebral ischemia-reperfusion injury.
Collapse
Affiliation(s)
- Qilan Jia
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province, 116044, China
| | - Xin Zhang
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province, 116044, China
| | - Ailin Zhang
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province, 116044, China
| | - Rui Wu
- School of Life Sciences, Liaoning Normal University, Dalian, Liaoning Province, 116029, China
| | - Zhien Liu
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province, 116044, China
| | - Yiheng Chen
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province, 116044, China
| | - Jihong Wang
- School of Life Sciences, Liaoning Normal University, Dalian, Liaoning Province, 116029, China.
| | - Li Lv
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province, 116044, China.
| |
Collapse
|
2
|
Jin Y, Lv L, Ning SX, Wang JH, Xiao R. The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells. Anticancer Agents Med Chem 2019; 19:2108-2119. [PMID: 31642792 DOI: 10.2174/1871520619666191022160024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Revised: 04/21/2019] [Accepted: 08/16/2019] [Indexed: 11/22/2022]
Abstract
BACKGROUND Laryngeal Squamous Cell Carcinoma (LSCC) is a malignant epithelial tumor with poor prognosis and its incidence rate increased recently. rLj-RGD3, a recombinant protein cloned from the buccal gland of Lampetra japonica, contains three RGD motifs that could bind to integrins on the tumor cells. METHODS MTT assay was used to detect the inhibitory rate of viability. Giemsa's staining assay was used to observe the morphological changes of cells. Hoechst 33258 and TUNEL staining assay, DNA ladder assay were used to examine the apoptotic. Western blot assay was applied to detect the change of the integrin signal pathway. Wound-healing assay, migration, and invasion assay were used to detect the mobility of Hep2 cells. H&E staining assay was used to show the arrangement of the Hep2 cells in the solid tumor tissues. RESULTS In the present study, rLj-RGD3 was shown to inhibit the viability of LSCC Hep2 cells in vitro by inducing apoptosis with an IC50 of 1.23µM. Western blot showed that the apoptosis of Hep2 cells induced by rLj- RGD3 was dependent on the integrin-FAK-Akt pathway. Wound healing, transwells, and western blot assays in vitro showed that rLj-RGD3 suppressed the migration and invasion of Hep2 cells by integrin-FAKpaxillin/ PLC pathway which could also affect the cytoskeleton arrangement in Hep2 cells. In in vivo studies, rLj-RGD3 inhibited the growth, tumor volume, and weight, as well as disturbed the tissue structure of the solid tumors in xenograft models of BALB/c nude mice without reducing their body weights. CONCLUSION These results suggested that rLj-RGD3 is an effective and safe suppressor on the growth and metastasis of LSCC Hep2 cells from both in vitro and in vivo experiments. rLj-RGD3 might be expected to become a novel anti-tumor drug to treat LSCC patients in the near future.
Collapse
Affiliation(s)
- Yang Jin
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China
| | - Li Lv
- Department of Pharmacology, Dalian Medical University, Dalian 116044, China
| | - Shu-Xiang Ning
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China
| | - Ji-Hong Wang
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China
| | - Rong Xiao
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China
| |
Collapse
|
3
|
Zheng YY, Xiao R, Zhang LX, Yan HJ, Wang JH, Lv L. A Novel Mutant of rLj-RGD3 (rLj-112) Suppressed the Proliferation and Metastasis of B16 Cells through the EGFR Signaling Pathway. Mar Drugs 2019; 17:md17020075. [PMID: 30821275 PMCID: PMC6409697 DOI: 10.3390/md17020075] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Revised: 01/14/2019] [Accepted: 01/17/2019] [Indexed: 12/25/2022] Open
Abstract
Lj-RGD3, which contains three Arg⁻Gly⁻Asp (RGD) motifs, was first identified from the buccal glands of Lampetra japonica and has been shown to suppress the tumor progression in the previous studies. Apart from the three RGD motifs, Lj-RGD3 is also characterized by its high content of histidine in its amino acid sequence. In order to clarify whether the histidine-rich characterization of Lj-RGD3 is also associated with its anti-tumor activity, mutants were designed in which the three RGD motifs (Lj-112), or all histidines (Lj-27) or both (Lj-26) were deleted. Furthermore, a mutant (Lj-42) in which all histidines and three RGD motifs were respectively substituted with alanines and three Ala⁻Gly⁻Asp (AGD) motifs, as well as a mutant (Lj-41) in which all histidines were substituted with alanines was synthesized to avoid alterations in structure which might further cause changes in the peptides' functions. After recombination and purification, recombinant Lj-112 (rLj-112), recombinant Lj-27 (rLj-27), recombinant Lj-41 (rLj-41), and recombinant Lj-RGD3 (rLj-RGD3) exhibited anti-proliferative activity in B16 cells, respectively; while recombinant Lj-26 (rLj-26) and recombinant Lj-42 (rLj-42) did not affect the proliferation of B16 cells significantly. In addition, the anti-proliferative activity of rLj-112 in B16 cells was due to apoptosis. Typical apoptosis features were observed, including chromatin condensation, fragmented DNA, and increased levels of cleaved caspase 3/caspase 7/nuclear enzyme poly (ADP-ribose) polymerase (PARP) in B16 cells. Similar to rLj-RGD3, rLj-112 was also capable of suppressing the migration and invasion of B16 cells by disturbing the F-actin arrangement. After labeling with FITC, rLj-112 was found localized in the cytoplasm of B16 cells, which induced the internalization of epidermal growth factor receptor (EGFR), suggesting that rLj-112 might block the EGFR mediated signaling pathway. Actually, the phosphorylation level of EGFR and its downstream signal molecules including Akt, PI3K, p38, and ERK1/2 was reduced in the rLj-112 treated B16 cells. In vivo, rLj-112 also inhibited the growth, weight, and volume of the tumors in B16 xenografted C57BL/6 mice without reducing their body weight, indicating that rLj-112 might be safe and might be used as an effective anti-tumor drug in the near future.
Collapse
Affiliation(s)
- Yuan-Yuan Zheng
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
| | - Rong Xiao
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
| | - Lu-Xin Zhang
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
| | - Hui-Jie Yan
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
| | - Ji-Hong Wang
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
| | - Li Lv
- Department of Pharmacology, Dalian Medical University, Dalian 116044, China.
| |
Collapse
|
4
|
rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice. Molecules 2017; 22:molecules22122234. [PMID: 29244724 PMCID: PMC6149813 DOI: 10.3390/molecules22122234] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2017] [Revised: 12/01/2017] [Accepted: 12/12/2017] [Indexed: 01/12/2023] Open
Abstract
In the previous study, rLj-RGD3, a recombinant toxin protein which contains three RGD motifs, was reported to not only inhibit the proliferation of an ovarian cancer cell line, HeyA8 cells, by inducing apoptosis, but also block their adhesion, migration and invasion processes. However, whether rLj-RGD3 could also suppress the tumor growth in HeyA8 xenografted mice has not been reported yet. In the present study, rLj-RGD3 was intraperitoneally injected in the nude mice bearing HeyA8 tumors. Compared with the control group (normal saline), rLj-RGD3 inhibited the tumor growth significantly in the HeyA8 xenografted mice in a dose-dependent manner without affecting their body weights. Based on the H&E, Hoechst 33258 and TUNEL staining assays, as well as western blot analysis, rLj-RGD3 reduced the weight and volume of the solid tumors, probably by disturbing the tissue structure, inducing apoptosis and suppressing the FAK/PI3K/AKT pathway. Most importantly, rLj-RGD3 was found to prolong the survival days of the ovarian tumor xenografted mice, which suggested rLj-RGD3 might act as an effective and safe drug to treat ovarian cancer patients.
Collapse
|
5
|
Jiang Q, Li Q, Han J, Gou M, Zheng Y, Li B, Xiao R, Wang J. rLj-RGD3 induces apoptosis via the mitochondrial-dependent pathway and inhibits adhesion, migration and invasion of human HeyA8 cells via FAK pathway. Int J Biol Macromol 2017; 96:652-668. [DOI: 10.1016/j.ijbiomac.2016.12.069] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Revised: 12/23/2016] [Accepted: 12/26/2016] [Indexed: 01/09/2023]
|
6
|
Wang Y, Zheng Y, Tu Z, Dai Y, Xu H, Lv L, Wang J. The anti-tumor effects of the recombinant toxin protein rLj-RGD3 from Lampetra japonica on pancreatic carcinoma Panc-1 cells in nude mice. Peptides 2017; 88:8-17. [PMID: 27988354 DOI: 10.1016/j.peptides.2016.12.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2016] [Revised: 12/10/2016] [Accepted: 12/13/2016] [Indexed: 02/06/2023]
Abstract
Recombinant Lampetra japonica RGD peptide (rLj-RGD3) is a soluble toxin protein with three RGD (Arg-Gly-Asp) motifs and a molecular weight of 13.5kDa. The aim of this study was to investigate the effects and mechanisms of rLj-RGD3 on tumor growth and survival in pancreatic carcinoma Panc-1 cell-bearing mice. A Panc-1 human pancreatic carcinoma-bearing nude mouse model was successfully generated, and the animals were treated with different doses of rLj-RGD3 for 3 weeks. The volume and weight of the subcutaneous tumors, the survival of the nude mice, histopathological changes, the intratumoral MVD, the number of apoptotic Panc-1 cells, and apoptosis-related proteins and gene expressions were determined. rLj-RGD3 significantly decreased the tumor volumes and weights, and the maximum tumor volume and weight IR values were 53.2% (p<0.001) and 55.9% (p<0.001), respectively. The life expectancy of Panc-1-bearing nude mice treated with rLj-RGD3 was increased by 56.3% (p<0.001). Meanwhile, rLj-RGD3 promoted the expression of Bax, caspase-3, and caspase-9 and inhibited Bcl-2 and VEGF expression. In addition, rLj-RGD3 did not change FAK, PI3K and Akt expression, but p-FAK, p-PI3K and p-Akt, levels were down-regulated. These results show that rLj-RGD3 induced potent anti-tumor activity in vivo and suppressed the growth of transplanted Panc-1 cells in a nude mouse model, implying that rLj-RGD3 may serve as a potent clinical therapeutic agent for human pancreatic carcinoma.
Collapse
Affiliation(s)
- Yue Wang
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province 116044, China
| | - Yuanyuan Zheng
- School of Life Sciences, Liaoning Normal University, Dalian, Liaoning Province 116029, China
| | - Zuoyu Tu
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province 116044, China
| | - Yongguo Dai
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province 116044, China
| | - Hong Xu
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province 116044, China
| | - Li Lv
- Department of Pharmacology, Dalian Medical University, Dalian, Liaoning Province 116044, China.
| | - Jihong Wang
- School of Life Sciences, Liaoning Normal University, Dalian, Liaoning Province 116029, China.
| |
Collapse
|
7
|
Shao F, Lv M, Zheng Y, Jiang J, Wang Y, Lv L, Wang J. The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice. Biochimie 2015; 119:183-91. [DOI: 10.1016/j.biochi.2015.11.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2015] [Accepted: 11/03/2015] [Indexed: 01/15/2023]
|
8
|
Chen X, Che X, Wang J, Chen F, Wang X, Zhang Z, Fan B, Yang D, Song X. Zinc sensitizes prostate cancer cells to sorafenib and regulates the expression of Livin. Acta Biochim Biophys Sin (Shanghai) 2013; 45:353-8. [PMID: 23435194 DOI: 10.1093/abbs/gmt017] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
In prostate carcinogenesis, normal zinc-accumulating epithelial cells are transformed into malignant cells that do not accumulate zinc. Increased levels of zinc have been shown to induce apoptosis through a caspase-dependent mechanism with down-regulated anti-apoptotic proteins in prostate cancer cells. Our previous study showed that, as a member of the inhibitor of apoptosis proteins (IAPs) family, Livin could play an important role in the initiation of human prostate cancer and promote cell proliferation by altering the G1-S cell cycle transition. In the present study, we measured the apoptosis sensitivity of prostate cancer cells to zinc and sorafenib and found that zinc sensitized prostate cancer cells to sorafenib-induced apoptosis. Surprisingly, we also found that, unlike its counterparts Survivin and cIAP2, Livin was not decreased all the time; instead, it was compensatively increased in zinc-mediated apoptosis at 48 h in prostate cancer cells. Our results offer potential treatment combinations that may augment the effect of sorafenib, and also reveal, for the first time, that increased Livin expression may play a role in the early cell death response of prostate cancer cells to zinc.
Collapse
Affiliation(s)
- Xiaochi Chen
- Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Jin M, Xiao R, Wang J, Liu X, Liu Y, Xue Z, Lv L, Zheng Y, Li Q. Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-α-induced human renal carcinoma cell invasion. Acta Biochim Biophys Sin (Shanghai) 2013; 45:377-82. [PMID: 23435195 DOI: 10.1093/abbs/gmt015] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
A hallmark of renal cell carcinoma (RCC) invasion is the degradation of the extracellular matrix (ECM) by the local production of gelatinase enzymes. Matrix metalloproteinase-9 (MMP-9)-induced cancer cell invasion is one of the pivotal steps in cancer metastasis. It has been reported that tumor necrosis factor-α (TNF-α), a regulator of MMP-9, can induce invasion in human renal carcinoma cells. Previous work in our laboratory has shown that rLj-RGD3, a recombinant RGD (Arg-Gly-Asp)-toxin protein from the buccal gland secretion of Lampetra japonica, possesses anti-tumor activity. In this study, we demonstrated that rLj-RGD3 suppressed TNF-α-induced MMP-9 secretion in 786-0 cells (human renal carcinoma cells). To investigate the regulatory effect of rLj-RGD3 on TNF-α-induced MMP-9 secretion, we pre-treated cells with rLj-RGD3. Interestingly, rLj-RGD3 had no significant effect on the constitutive secretion of MMPs. However, low concentrations of rLj-RGD3 decreased TNF-α-induced MMP-9 secretion. Functional studies revealed that rLj-RGD3 induced apoptosis and significantly inhibited the proliferation, migration, and invasion of 786-0 cells. Furthermore, the actin architecture in cells pre-treated with rLj-RGD3 was aggregated and disorganized. Our findings suggest that rLj-RGD3 may be used as a potential drug in renal cancer therapy.
Collapse
Affiliation(s)
- Minli Jin
- College of Life Sciences, Liaoning Normal University, Dalian 116021, China
| | | | | | | | | | | | | | | | | |
Collapse
|